Proximity is measured over citations between two papers we both hold, weighted by how heavily one leans on the other, and is symmetric — it does not distinguish citing from being cited. Authors without a profile here are skipped, and a genuinely close colleague can be missing simply because their work is not in our arXiv corpus. Method: docs/06-citations-pipeline.md.
Papers
(1 of 61)
Observational Comparative Research in Cardiovascular and Brain Health and Disease: A Scientific Statement From the American Heart Association
published2026 · Circulation
with Brian Mac Grory, Joshua A. Beckman, Hooman Kamel, Jay B. Lusk, Catherine M Otto, Joy Shi, Eric E. Smith, Ying Xian, Kori S. Zachrison
Bridging Treatment Implementation Gaps in Patients With Heart Failure
published2023 · Journal of the American College of Cardiology · 45 citations
with Mohamed B. Jalloh, Tauben Averbuch, Prashanth Kulkarni, Christopher B. Granger, James L. Januzzi, Faïez Zannad, Clyde W. Yancy, Gregg C. Fonarow, Khadijah Breathett, C. Michael Gibson, Harriette G.C. Van Spall
Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study
published2023 · Journal of the American Heart Association · 9 citations
with Kamil F. Faridi, Jordan B. Strom, Harun Kundi, Neel M. Butala, Jeptha P. Curtis, Qi Gao, Yang Song, Luke Zheng, Hector Tamez, Changyu Shen, Eric A. Secemsky
THE INFLATION REDUCTION ACT'S OUT-OF-POCKET PRESCRIPTION DRUG COST CAP WILL BENEFIT OVER 1 MILLION MEDICARE PATIENTS WITH CARDIOVASCULAR RISK FACTORS OR DISEASE
published2023 · Journal of the American College of Cardiology · 1 citations
with Prihatha Narasimmaraj, Andrew S. Oseran, Archana P. Tale, Jiaman Xu, Dhruv S. Kazi, Rishi K. Wadhera
Medicare eligibility and healthcare access, affordability, and financial strain for low-and higher-income adults in the United States: A regression discontinuity analysis
published2022 · PLoS Medicine · 22 citations
with Rahul Aggarwal, Issa J Dahabreh, Sarah E. Robertson, Rishi K. Wadhera
Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis
published2021 · Circulation Cardiovascular Quality and Outcomes · 13 citations
with Craig Rodrigues, Ayodele Odutayo, Sagar Patel, Arnav Agarwal, Bruno R. da Costa, Ethan Lin, Peter Jüni, Shaun G. Goodman, Michael E. Farkouh, Jacob A. Udell, Arnav Argarwal, Shaun Goodman, …
RECLASSIFICATION OF HOSPITAL PERFORMANCE USING THE EXCESS DAYS IN ACUTE CARE MEASURE VS. 30-DAY READMISSIONS FOR HEART FAILURE AND ACUTE MYOCARDIAL INFARCTION: IMPLICATIONS FOR THE HOSPITAL READMISSIONS REDUCTION PROGRAM
published2020 · Journal of the American College of Cardiology
with Rishi K. Wadhera, Karen E. Joynt Maddox, Nihar R. Desai, Muthiah Vaduganathan, Lauren Gilstrap, Changyu Shen
ASSESSING FRAILTY-ASSOCIATED CHARACTERISTICS AND OUTCOMES IN THE DUAL ANTIPLATELET THERAPY (DAPT) STUDY USING MEDICARE CLAIMS: INSIGHTS FROM THE EXTEND-DAPT STUDY
published2020 · Journal of the American College of Cardiology
with Kamil F. Faridi, Harun Kundi, Jordan B. Strom, Jeptha P. Curtis, Qi Gao, Yang Song, Hector Tamez Aguilar, Laura Mauri, Changyu Shen
Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study
published2019 · American Heart Journal · 31 citations
with Jordan B. Strom, Hector Tamez, Yuansong Zhao, Linda R. Valsdottir, Jeptha P. Curtis, James M. Brennan, Changyu Shen, Jeffrey J. Popma, Laura Mauri
LINKING THE NCDR CATHPCI REGISTRY WITH ADMINISTRATIVE CLAIMS TO DETERMINE ATTRIBUTION OF REPEAT REVASCULARIZATION FOLLOWING INDEX DRUG-ELUTING STENT IMPLANTATION
published2019 · Journal of the American College of Cardiology
with Sanket S. Dhruva, Craig S. Parzynski, Jeptha P. Curtis, Nihar R. Desai, Frederick A. Masoudi, Sharon-Lise T. Normand, Richard Kuntz, Richard K. Shaw, Danica Marinac-Dabic, Harlan M. Krumholz, Joseph S. Ross
NEIGHBORHOOD DISADVANTAGE AND VARIATIONS IN CORONARY ARTERY DISEASE CARE AND OUTCOMES AMONG OUTPATIENT CARDIOLOGY PRACTICES
published2019 · Journal of the American College of Cardiology
with Rishi K. Wadhera, Yang Song, Amy Kind, Deepak L. Bhatt, Liyan Dong, Gheorghe Doros, Alexander Turchin, Thomas M. Maddox, Kim A. Williams, Karen E. Joynt Maddox
HOSPITAL RANKINGS FOR MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION COMPARED WITH RANKINGS FOR MORTALITY AFTER PERCUTANEOUS CORONARY INTERVENTION IN NEW YORK STATE
published2019 · Journal of the American College of Cardiology
with Ashwin S. Nathan, Sameed Ahmed M. Khatana, Peter W. Groeneveld, Jay Giri
IMPLICATIONS OF THE DUAL-ANTIPLATELET THERAPY (DAPT) TRIAL IN THE REAL WORLD: INSIGHTS FROM THE NCDR RESEARCH TO PRACTICE INITIATIVE
published2017 · Journal of the American College of Cardiology
with Amneet Sandhu, P. J. Stewart, Steven M. Bradley, John C. Messenger, James A. de Lemos, Michael Ho, Javier A. Valle, Gregory P. Hess, John Rumsfeld, Frederick A. Masoudi, Thomas M. Maddox
Time-Course of Cause-Specific Hospital Admissions During Snowstorms: An Analysis of Electronic Medical Records From Major Hospitals in Boston, Massachusetts
published2016 · American Journal of Epidemiology · 29 citations
with Jennifer F. Bobb, Kalon K.L. Ho, L. Garth Harrington, Adrian Zai, Katherine P. Liao, Francesca Dominici
TCT-282 Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CTO Study
published2016 · Journal of the American College of Cardiology · 4 citations
with Robert F. Riley, James Sapontis, Philip G. Jones, Ajay J. Kirtane, Dimitri Karmpaliotis, J. Aaron Grantham, William Lombardi, Emmanouil S. Brilakis, James M. McCabe
TCT-281 Development and Validation of a Scoring System for Predicting Major Adverse Cardiovascular Events during Percutaneous Coronary Interventions of Chronic Total Occlusions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) MACE Score
published2016 · Journal of the American College of Cardiology
with Barbara A. Danek, Aris Karatasakis, Dimitri Karmpaliotis, Khaldoon Alaswad, Farouc A. Jaffer, Mitul Patel, John Bahadorani, William Lombardi, R. Michael Wyman, J. Aaron Grantham, Anthony Doing, David E. Kandzari, …
Letter by Wasfy et al Regarding Article, “Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System (VA CART) Program”
TCT-204 Comparable Outcomes despite Differences in Patient Representation between Premarket and Postmarket coronary Intervention Studies: Findings from the ENDEAVOR and PROTECT Programs
published2013 · Journal of the American College of Cardiology
with Moshe Vardi, Jeremiah Perez, David Burke, Donald E. Cutlip
Abstract P4: Does the Expected Reduction in Restenosis from Drug-Eluting Stents Predict Actual Use? An Assessment of Treatment-Risk Paradox Using the C-Statistic
published2011 · Circulation Cardiovascular Quality and Outcomes
with Sharon-Lise T. Normand, Laura Mauri, Robert Wolf, David J. Cohen, Kalon K.L. Ho, John A. Spertus
Assembled from arXiv and OpenAlex. Duplicate records for the same paper are merged, and the published version is shown where we could identify one. Corrections welcome.